Aims: To investigate the differences and international connections between the human cervical cancer cell line (HeLa cells) and the Taxol-resistant HeLa cell line (HeLa/Taxol).
INTRODUCTION
Cervical cancer is one of the most common gynecological malignant tumors with the second incidence in female malignant tumors, which causes serious damage to the women's health. Chemotherapy is an important means to treat cervical cancer. However, tumor cells often show cross-resistance to multichemotherapy drugs with various structures and different mechanisms during chemotherapy. The multidrug resistance (MDR) of tumor cells is a major cause of chemotherapy failure, tumor recurrence, and even patients death. Hence, to research the mechanism of MDR and to prevent or reverse MDR can greatly improve the chemotherapy effects of cervical cancer. [1] In recent years, the establishment of drug-resistant tumor cell line is generally used to study the mechanisms of MDR, new anticancer treatments reversing the MDR of tumor cells as well as to evaluate treatment effects. [2] This study aims to establish human cervical cancer HeLa line resistant to Taxol, and explore the biological characteristics of the drug-resistant cell line in preliminary studies, which will provide effective cell model for the research on drug resistance mechanisms of tumor. glutathione S-transferase π (GST-π), survivin monoclonal antibodies were purchased from Abcam company. Rat and rabbit antihuman actin antibodies were purchased from CedarBridge company in Beijing. Rat and rabbit antihuman secondary antibodies and 5× loading buffer were purchased from Thermo company (USA). Immunofluorescence staining kits and protein lysate were purchased from Beyotime Biotechnology Research Institute. Inverted fluorescence microscope (Leica company, Germany), low temperature high speed centrifuge (Eppendorf company, Germany), polymerase chain reaction (PCR) (Bio-Rad company, USA), Multiskan MK3 enzyme standard instrument (Thermo, USA), clean bench (Sujing Antai), and cell incubator (Thermo, USA) were all used.
Cell culture
HeLa cells were cultured in 1640 medium supplemented with 10% newborn bovine serum in a humidified (5% CO 2 , 37°C) incubator, refreshed every 1-2 days, and passaged every 3-4 days.
The establishment of Taxol-resistant cell line
With HeLa as the parental cells, cervical cancer HeLa/Taxol cells resistant to Taxol were induced and screened by increasing concentrations. From low concentration (0.01 µg/ml, 11.7 × 10 −9 mol/L), after 48 h co-incubation, discard drug containing culture medium, add fresh culture liquid containing 15% fetal bovine serum, continue to culture until the cells returned to normal growth and density reached 70%, then digest and passage, and repeat the above operation. According to cell growth, gradually increase the drug concentration of intermittent induction and ultimately get the taxol-resistant concentration of 0.5 µg/ml. The process lasted for about 9 months. To prevent fast fade of cell resistance, cells were cultured without 0.5 µg/ml Taxol on the first day after digestion and passage or when density was <30%. MTT method was used to detect HeLa and HeLa/Taxol light density value (test wavelength 570 nm), and growth curve was drawn.
Methyl-thiazolyl-tetrazolium test
After continuous detection of optical density (OD) in HeLa and HeLa/Taxol for 6 days using MTT method, growth curve was drawn.
Real-time polymerase chain reaction
HeLa and HeLa/Taxol cells were seeded in 6-well culture plates with 5 × 10 5 cell density in a humidified (5% CO 2 , 37°C) incubator for 48 h. Real-time PCR (RT-PCR) was performed to detect the messenger RNA (mRNA) levels of P-gp, GST-π, Bcl-2, survivin, actin in HeLa, and HeLa/Taxol cells. Total RNA was extracted according to the TRIzol Reagent Kit. Ultraviolet (UV) spectrophotometer was used to detect the purity of RNA (A260/A280 in 1.8-2.0), and the concentration of total RNA was measured. Reverse transcription reaction system and condition were set according to the Revert Aid™ First Strand cDNA Synthesis Kit (Fermentas). PCR reaction was performed according to the TaKaRa Taq Kit. Primer sequences were as follows: P-gp: upstream 5'-GTTCAAACTTCTGCTCCTGA-3', downstream 5 '-CCCATCATTGCAATAGCAGG-3'; GST-π: upstream 5'-GGAGACCTCACCCTGTACCA-3', downstream 5'-GGCTAGGACCTCATGGATCA-3'; Bcl-2: upstream 5 ' -G C TAC G AGT G G G ATAC T G G AG A -3 ' , d o w n s t re a m 5'-AGTCATCCACAGAGCGATGTT-3'; Survivin: upstream 5 ' -AC T G AG A AC G AG C C AG AC T T G -3 ' , d o w n s t re a m 5'-CGCACTTTCTCCGCAGTTTC-3'. PCR products were taken 1% agarose gel electrophoresis. PCR results were observed and photographed under UV lamp. Using mRNA ImageJ was used for relative content of mRNA analysis of P-gp, Bcl-2, Survivin, GST-π, and actin.
Immunofluorescence
Immunofluorescence was used to detect the expression of P-gp, GST-π, Bcl-2, and Survivin in HeLa, and HeLa/Taxol cells. Sterilized 20 mm glass coverslips were placed in 6-well culture plate, and HeLa and HeLa/Taxol cells were cultured in the culture plate according to 5 × 10 5 cell density for cell climbing piece in a humidified (5% CO 2 , 37°C) incubator for 48 h. Cells were treated in the order of cleaning, fixing, drying, and cleaning. Cells were incubated with 3% H 2 O 2 -methanol for 15 min to remove the endogenous peroxidase activity. Then, cells were blocked with goat serum for 40 min at room temperature. After dropping sheep serum blocking solution, cells were incubated with anti-Bcl-2, anti-P-gp, anti-GST-PI, and anti-Survivin in 1:200 dilution ratio in a wet box at 4°C overnight. The goat anti-rabbit fluorescence secondary antibody labeled with fluorescein isothiocyanate was added and incubated for 30 min was incubated at 37°C. Cells were washed with phosphate-buffered saline (PBS) and stained with Hoechst for 20 min 37°C. Mount with 50% glycerol after washing with PBS. Image with fluorescence microscopy (BX60, Olympus) was performed. The experiment was repeated three times.
Western blot
Western blot was performed to detect the expression of P-gp, GST-π, Bcl-2, and Survivin in HeLa and HeLa/Taxol cells. Total protein was extracted with RIPA cell lysate, loaded on 2.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and then transferred onto nitrocellulose (NC) membranes, followed by sealing with 5% skim milk at room temperature for 1 h. Then, the NC membrane was incubated with mouse antihuman P-gp (1:500), Bcl-2 (1:400), and GAPDH (1:2000), Rabbit antihuman GST-π, survivin (1:400) overnight at 4°C. After that, the NC membrane was washes three times with TBST solution and incubated with anti-rat and rabbit secondary antibodies (1:5000) at 37°C for 1 h. The signals were detected with ECL and analyzed with ImageJ.
Statistical analysis
All assays were performed at least three times independently. All the error bars represented as the mean ± standard deviation (n = 3). T-test in SPSS 17.0 software (International Business Machines Corporation, Armonk, NY, USA) was used for statistical analysis. Significance was defined as P < 0.05.
RESULTS

Establishment of drug-resistant cell line and the comparison of the growth characteristics between the two cell lines
The two cell lines were cultured with the same density. The growth trends and morphology of cells were observed at 1, 2, and 3 days respectively after passage. The results showed that drug-resistant cell line grew slowly, the volume was bigger, the cell was full, and the synapse disappeared [ Figures 1 and 2] .
Messenger RNA levels of multidrug resistance protein, antiapoptotic gene and apoptosis inhibitor gene in HeLa and HeLa/Taxol cells by RT-polymerase chain reaction
RT-PCR results showed that the expression levels of drug-resistant P-gp gene, GST-π, antiapoptotic gene Bcl-2, and apoptosis inhibitor gene survivin were all significantly increased in HeLa/Taxol cells, compared to HeLa cells (P < 0.05) [ Figure 3 ].
Expression of P-gp, glutathione S-transferase-π, Bcl-2, and Survivin in HeLa and HeLa/Taxol cells by immunofluorescence
Ten visions were detected under optical microscopy ×200. The number of positive cells per 100 cells was calculated as the average positive rate. The results showed that positive rate of Bcl-2 (a-1, b-1), P-gp (a-2, b-2), GST-π (a-3, b-3), and survivin (a-4, b-4) in HeLa/Taxol cells were significantly more than that in HeLa cells (P < 0.05) [ Figure 4 and Table 1 ].
Protein levels of multidrug resistance protein, antiapoptotic gene and apoptosis inhibitor gene in HeLa and HeLa/Taxol cells by Western blot
The results showed that the protein levels of drug-resistant P-gp gene, GST-π, antiapoptotic gene Bcl-2, and apoptosis inhibitor gene survivin were all significantly increased in HeLa/Taxol cells, compared to HeLa cells (P < 0.05) [ Figures 5 and 6] , which was consistent with the mRNA results, indicating that the mechanisms of increased drug resistance and antiapoptosis of HeLa/Taxol cells.
DISCUSSION
With treatments of cervical cancer becoming more and more perfect and chemotherapy drugs being continuously produced, people gradually realize that the chemical treatments play an important role in cervical cancer. However, MDR of cervical cancer has greatly limited the efficacy of chemotherapy drugs, resulting in failure of chemotherapy and even tumor recurrence. [3] MDR of tumor cells is a complex process that combines multiple genes, multiple factors, and multiple steps. The most common resistance gene is P-gp, coded by MDR1 gene, a membrane glycoprotein. The molecular weight is 170 kD and -2 (a-1, b-1), P-gp (a-2, b-2 -π (a-3, b-3), and survivin (a-4, b-4 composed of 128 amino acids. Most of P-gp is located in cell membrane with a small amount in endoplasmic reticulum and Golgi. P-gp is an energy dependent medicine pump. Drug binds to the nucleotide binding site of the gene. The energy released after hydrolysis pumps the drug out of the cell, resulting in the decline of drug concentration in tumor cell, which will make the killing effect of chemotherapy drugs on tumor cell reduced or complete loss, developing resistance. [4, 5] High expression of P-gp is one of the main causes for the production of MDR. In this study, the expression of P-gp in drug-resistant cell HeLa/Taxol was significantly higher than that of HeLa, which fully demonstrated that the induced HeLa/Taxol cells were resistant to drug.
), glutathione S-transferase
Another common resistance gene GST-π is a dimeric enzyme family, localized in cytoplasm, endoplasmic reticulum, and mitochondria. GST-π can catalyze the conjunction of glutathione with electrophilic drugs such as various alkylating agents, increase the water solubility, and accelerate the excretion of drugs, which decreases the efficacy. In addition, GST-π scavenges free radicals produced by anthracyclines, reducing the damage to cells. GST-π also decreases drug activity in the form of direct combination with drugs. [6] GST-πexpression in tumor cells is significantly less than P-gp. In our study, GST-πexpression in HeLa/Taxol cells was slightly higher than the HeLa cell. Although not as obvious as P-gp, the difference still had statistical significance (P < 0.05), also proving the existence of drug resistance in HeLa/Taxol.
Survivin is an apoptosis suppressor gene, widely existing in prokaryotic and eukaryotic cells. It can regulate cell division and inhibit apoptosis. It is the most powerful inhibitor of apoptosis protein so far, inhibiting apoptosis induced by a variety of factors and promoting cell survival, which enhances cell abnormal proliferation and malignant transformation. Survivin can directly inhibit the activity of caspase-3 and casepase-7, effectively blocking the apoptosis. The mechanism is recognized as an important reason for MDR. [4] [5] [6] [7] In this experiment, the expression of survivin gene in drug-resistant cell line HeLa/ Taxol was significantly higher than that of HeLa, confirming that the induced HeLa/Taxol cells are resistant to drugs.
Bcl-2 protein family is one of the most studied cell apoptosis-related genes, which can inhibit the tumor cell apoptosis through a variety of mechanisms. Its mechanism has been extensively studied, and once again it is not described in the study. In this study, the expression of Bcl-2 gene in drug-resistant cell HeLa/Taxol was significantly higher than that of HeLa, which showed that HeLa/Taxol had stronger antiapoptotic ability.
The aim of this study is to establish human cervical cancer HeLa line resistant to Taxol, compare the biological characteristics of the two cell lines and further explore the inner links, providing theoretical guidance for clinical reversal of MDR. The establishment of human cervical cancer HeLa line resistant to Taxol supplies an important research carrier for developing new treatment to inhibit MDR.
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